Topical and oral emodepside formulations for last-line treatment of multianthelmintic drug-resistant hookworms when given orally to dogs are not bioequivalent
American Journal of Veterinary Research · 2025
DOI: 10.2460/ajvr.25.01.0027 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Veterinary Research, 2025. Verfasst von Theresa A Quintana und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostic Medicine and Pathobiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS. Hauptthemen laut MEDLINE: Dog Diseases, Depsipeptides, Hookworm Infections, Anthelmintics. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objective
To evaluate the pharmacokinetics of emodepside in dogs following single-dose administration of the FDA-approved feline topical solution orally and topically and the European Medicines Agency–approved canine modified-release tablet orally and to assess the bioequivalence of the feline topical solution administered orally compared to the canine modified-release tablet.
Methods
This study was conducted in 3 phases, during which dogs received single doses of emodepside as the feline topical solution (1 mg/kg) orally, the canine modified-release tablet (1 mg/kg) orally, and the topical feline solution (3 mg/kg) topically. Plasma pharmacokinetic profiles were determined for 21 days postdose. Bioequivalence testing was conducted for orally administered emodepside.
Results
7 healthy client-owned dogs (4 female and 3 male) were prospectively enrolled in this crossover study from May through August 2023. Oral administration of the feline topical solution resulted in markedly greater emodepside absorption than the modified-release tablet and was not bioequivalent. Emodepside plasma concentrations following topical administration of the FDA formulation were 36- to 122-fold lower than after oral administration.
Conclusions
The feline topical solution administered orally at 1 mg/kg is not bioequivalent to the canine modified-release tablet. Markedly higher absorption of the feline topical solution administered orally raises potential safety concerns for extralabel use in dogs to treat multianthelmintic drug-resistant hookworm infections. Poor absorption following topical administration suggests it may be unsuitable for treating multianthelmintic drug-resistant hookworm infections. Clinical Relevance These findings highlight potential emodepside toxicity risks with extralabel use of the FDA-approved topical feline product and help inform safe off-label use in dogs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Diagnostic Medicine and Pathobiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS.
- Department of Pathobiology, College of Veterinary Medicine, Auburn University, Auburn, AL.
- Department of Anatomy and Physiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS.
- Department of Clinical Sciences, College of Veterinary Medicine, Kansas State University, Manhattan, KS.
- Department of Veterinary Clinical and Life Sciences, College of Veterinary Medicine, Utah State University, Logan, UT.
ORCID-Profile: Theresa A Quintana, Maria C Jugan, Jeba R J Jesudoss Chelladurai, Stephanie E Martinez
Zitieren
APA
Quintana, T. A., Karwath, G. N., Mayhue, E. J., Jugan, M. C., Jesudoss Chelladurai, J. R. J., & Martinez, S. E. (2025). Topical and oral emodepside formulations for last-line treatment of multianthelmintic drug-resistant hookworms when given orally to dogs are not bioequivalent. American Journal of Veterinary Research. https://doi.org/10.2460/ajvr.25.01.0027
Vancouver
Quintana TA, Karwath GN, Mayhue EJ, Jugan MC, Jesudoss Chelladurai JRJ, Martinez SE. Topical and oral emodepside formulations for last-line treatment of multianthelmintic drug-resistant hookworms when given orally to dogs are not bioequivalent. American Journal of Veterinary Research. 2025. doi:10.2460/ajvr.25.01.0027
BibTeX
@article{Quintana2025,
author = {Quintana, Theresa A and Karwath, Greta N and Mayhue, Erin J and Jugan, Maria C and Jesudoss Chelladurai, Jeba R J and Martinez, Stephanie E},
title = {Topical and oral emodepside formulations for last-line treatment of multianthelmintic drug-resistant hookworms when given orally to dogs are not bioequivalent},
journal = {American Journal of Veterinary Research},
year = {2025},
doi = {10.2460/ajvr.25.01.0027}
}
EUVIMED